Black technology: a super empire spanning two worlds

Chapter 175 [Interview]

Zhongguo CRRC has been very popular in the capital market recently, but its popularity has now been snatched away by Lingjing Technology's entry into the fields of modern bioengineering and medical devices.

In particular, the discussion on single-organ cloning technology has entered the public eye with a Weibo post by Xiao Yu.

On Friday, February 2, Xiao Yu gave a rare interview to a mainstream media on organ cloning technology.

At around 16 p.m., two media reporters who were interviewing Xiao Yu came to Lingjing Technology Company and recorded a face-to-face interview video with Xiao Yu in a reception room of the company.

At this moment, this face-to-face interview is already underway.

"…Lingjing Technology has entered the field of modern bioengineering and invested heavily in the development and application of single-organ cloning technology. After the announcement of this news, it has caused widespread discussion in society and also caused people to worry about the impact on the current medical system and social concepts."

The reporter looked at Xiao Yu and said clearly: "If single-organ cloning technology is applied on a large scale, some senior people believe that it will have a profound impact on the current medical system. Industry insiders believe that in terms of resource allocation, the high initial R&D costs and complex cultivation processes will inevitably lead to high prices for cloned organs, which may lead to further tilting of medical resources towards patients with financial strength."

"For example, high-end private hospitals may be able to take the lead in introducing technology and provide services to a small number of paying patients, while the public medical system lags behind in equipment and talent training due to funding constraints, exacerbating the 'organ access gap' between rich and poor patients, triggering social fairness disputes, and causing organ transplantation to fall from 'equal life opportunities' to the dilemma of 'money-dominated allocation'."

"Medical insurance policies may also face huge pressure for adjustment. Whether to include cloned organ transplants in the reimbursement scope has become a difficult problem. If it is fully covered, medical insurance funds will bear the risk of huge expenditures, affecting other basic medical insurance; if it is excluded, most patients will be turned away, which goes against the original intention of medical insurance to 'cover widely and protect the basics'."

The reporter raised a very profound and sharp question at the beginning.

Finally, Xiao Yu said: "These problems cannot be avoided. They will inevitably have a huge impact on the existing medical system and social concepts."

"From a social perspective, single-organ cloning technology challenges the foundation of traditional views on life. It blurs the boundaries between natural organs and artificial cloned organs, prompting people to rethink philosophical propositions such as the beginning of life and bodily integrity. It weakens some people's inherent understanding that life is a 'natural gift and unique', and may cause confusion at the level of spiritual beliefs."

"This requires society to build a new ethical adjustment mechanism and reshape values that match technological development in order to peacefully accept the changes in this disruptive technology. How to make trade-offs is a test of the wisdom of policymakers, as it involves complex interest games and social and livelihood considerations."

At this point, Xiao Yu thought for a moment in front of the camera, then looked at the interviewer and said methodically: "But there is one thing that is certain, and it is also a principle that must be adhered to. That is, if we succeed in single-organ cloning technology one day, organ transplantation must adhere to the principle of 'equal life opportunities', rather than a situation where 'money dominates allocation'."

Xiao Yu confidently added: "This interview video can be preserved. If one day 'money-dominated distribution' really occurs, this video can be used to lash out at the corpse. For me, insisting on 'equal opportunities in life' is non-negotiable."

This surprised the interviewer, who immediately asked, "Can this be done? Especially in the early stages, the price must be very high."

Xiao Yu said succinctly: "If the price is high, then don't use it yet. Let's lower the price before popularizing it. We are willing to take the initiative to bear the research and development costs first."

Uh... the reporter who interviewed him was also stunned. He didn't expect that he would speak so simply and directly. Xiao Yu wanted to say it so directly, without any detours. Only by being so clear and down-to-earth can he win the support of the majority of ordinary people in society.

After a while, Xiao Yu further said: "For this matter, our expected goal is to reduce the comprehensive cost of organ transplantation to about 30,000 to 50,000 yuan, so that most people can afford it. If we can't achieve this goal, we will definitely not commercialize it."

The reporter who interviewed him was also shocked to hear this. To be able to enjoy an organ transplant surgery for only 30,000 to 50,000 yuan is something that cannot even be imagined considering the current transplant surgery costs of hundreds of thousands or even millions of yuan.

The reporter couldn't help but say: "If the price is really reduced to this figure, then ordinary people can indeed afford it, but how easy is it?"

Hearing this, Xiao Yu smiled and said, "Someone has to do it. The application scenarios of single-organ cloning technology are far beyond the current imagination."

"For example, in the field of rare diseases, for single-gene hereditary rare diseases such as cystic fibrosis and Huntington's disease, single-organ cloning technology can accurately customize healthy organs and replace damaged tissues, breaking the dilemma of traditional treatments with no drugs available and extremely poor prognosis, lighting up hope for patients, rewriting the rules for diagnosis and treatment of rare diseases, and turning such rare diseases from 'incurable diseases' into controllable chronic diseases."

"In battlefield emergency scenarios, portable cloning equipment combined with bioprinting technology can quickly 'manufacture' skin, muscles, blood vessels and other trauma repair organs on the front line, treat the wounded in time, significantly reduce casualties, and shorten the recovery period of the wounded. It can change the current war trauma treatment model and improve the military's wartime medical support capabilities."

"In the future space exploration journey, the space station will be equipped with an organ cloning laboratory to provide organ damage repair protection for astronauts on long-term space flights, overcome the risk of organ diseases caused by space radiation, help humans move towards deep space exploration, and expand the boundaries of interstellar survival."

Xiao Yu paused for a moment, then continued, "Once single-organ cloning technology is put into large-scale clinical application, human society will inevitably enter a new stage. The average life expectancy is expected to be significantly extended, or even doubled. Centenarians or even 200-year-olds will become common, and the aging population structure will be reshaped."

"The social elderly care model can also transform from disease care to active elderly care, giving rise to the vigorous development of the elderly health industry, covering diverse fields such as high-end rehabilitation and elderly entertainment."

"In addition, the allocation of medical resources will be profoundly adjusted. Preventive cloning of organ reserves will become the norm. Early disease intervention will be popularized, significantly reducing the burden of terminal diseases. The flow of medical insurance funds will be optimized, shifting from disease treatment to health maintenance. More resources will be released to invest in public health and disease prevention, pushing human society into a new era of health, longevity and vitality."

The interviewing reporters felt incredible when they heard these words, especially when Xiao Yu said that people aged 200 might become a common group.

The blueprint for the future that Xiao Yu described is so fascinating. Who doesn’t want to live longer?
Once this technology is truly realized, it will definitely profoundly change the current social structure of all mankind. It will be a truly subversive revolution.

However, the reporter couldn't help but mutter in his heart that if this technology is really realized and popularized on a large scale, there is no need to think about delaying retirement, it will definitely happen.

Maybe the retirement age will be delayed to over 100 years old, and living to over 100 years old is still in the prime of life. The realization of this technology will absolutely bring subversive changes to human society in all aspects.

……

(End of this chapter)